- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x ACT: ACETATE ION(Non-functional Binders)
- 11 x SO4: SULFATE ION(Non-functional Binders)
SO4.7: 5 residues within 4Å:- Chain A: R.301, I.336, A.337, S.340, R.371
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:A.337, A:S.340
- Salt bridges: A:R.301, A:R.371
SO4.8: 4 residues within 4Å:- Chain A: L.1, D.2, R.189, Q.190
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.2
- Salt bridges: A:R.189
SO4.9: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)SO4.10: 3 residues within 4Å:- Chain A: S.145, L.146, E.147
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:L.146, A:E.147
SO4.11: 2 residues within 4Å:- Chain A: H.94, R.165
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:H.94, A:R.165
SO4.12: 2 residues within 4Å:- Chain A: K.182, R.221
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.182, A:R.221
SO4.28: 5 residues within 4Å:- Chain B: R.301, I.336, A.337, S.340, R.371
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:A.337, B:S.340
- Salt bridges: B:R.301, B:R.371
SO4.29: 4 residues within 4Å:- Chain B: L.1, D.2, R.189, Q.190
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:L.1
- Salt bridges: B:R.189
SO4.30: 5 residues within 4Å:- Chain B: Q.219, Q.299, L.300, R.301, Q.302
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.219, B:L.300, B:Q.302
SO4.31: 4 residues within 4Å:- Chain B: G.85, I.86, R.87, W.131
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:I.86, B:R.87, B:W.131
- Water bridges: B:A.77, B:W.131
SO4.32: 1 residues within 4Å:- Chain B: K.209
3 PLIP interactions:3 interactions with chain B- Water bridges: B:K.209, B:E.327
- Salt bridges: B:K.209
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.13: 4 residues within 4Å:- Chain A: W.178, P.179, F.180, Q.181
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:F.180
EDO.14: 3 residues within 4Å:- Chain A: D.213, W.214, F.217
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.213
EDO.15: 3 residues within 4Å:- Chain A: A.53, G.54, Q.290
No protein-ligand interaction detected (PLIP)EDO.16: 5 residues within 4Å:- Chain A: S.273, Q.275
- Chain B: W.246
- Ligands: PEG.38, PEG.39
8 PLIP interactions:2 interactions with chain B, 6 interactions with chain A- Hydrogen bonds: B:W.246, A:S.273, A:S.273, A:Q.275
- Water bridges: B:S.245, A:Q.249, A:Q.249, A:S.273
EDO.17: 5 residues within 4Å:- Chain A: F.198, A.199, D.200, S.207, S.210
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.200, A:S.210
EDO.18: 5 residues within 4Å:- Chain A: A.278, L.279, D.282, P.358, V.359
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:A.278
- Water bridges: A:K.360
EDO.19: 4 residues within 4Å:- Chain A: N.184, Y.185, T.186, R.221
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.184, A:Y.185, A:T.186, A:T.186, A:R.221
EDO.20: 3 residues within 4Å:- Chain A: R.361, R.373, H.375
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.361, A:H.375, A:H.375
EDO.33: 3 residues within 4Å:- Chain B: S.370, R.371, R.373
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.371, B:R.373
EDO.34: 3 residues within 4Å:- Chain B: T.335, R.371, R.373
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.371, B:R.373
EDO.35: 3 residues within 4Å:- Chain B: A.53, I.286, Q.290
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:A.53
EDO.36: 5 residues within 4Å:- Chain B: A.278, L.279, D.282, P.358, V.359
No protein-ligand interaction detected (PLIP)- 2 x YTW: (3~{a}~{R},4~{S},5~{S},6~{S},7~{R},7~{a}~{S})-7-(hydroxymethyl)-2,2-bis(oxidanylidene)-3~{a},4,5,6,7,7~{a}-hexahydro-3~{H}-benzo[d][1,2,3]oxathiazole-4,5,6-triol(Non-covalent)
YTW.21: 12 residues within 4Å:- Chain A: W.16, D.61, D.62, Y.103, C.111, A.112, K.137, D.139, E.172, Y.176, R.196, D.200
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:W.16
- Hydrogen bonds: A:D.61, A:D.62, A:A.112, A:K.137, A:E.172, A:R.196, A:R.196, A:D.200
- Water bridges: A:D.200, A:D.235
YTW.37: 11 residues within 4Å:- Chain B: W.16, D.61, D.62, Y.103, C.111, K.137, D.139, E.172, Y.176, R.196, D.200
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:W.16
- Hydrogen bonds: B:D.61, B:D.62, B:D.62, B:K.137, B:E.172, B:R.196, B:R.196
- Water bridges: B:D.200, B:D.200, B:D.235
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.22: 4 residues within 4Å:- Chain A: G.85, I.86, R.87, W.131
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:I.86, A:R.87, A:R.87, A:W.131
PEG.23: 6 residues within 4Å:- Chain A: P.358, R.361, H.375, I.376, N.377, V.382
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.361, A:N.377
- Water bridges: A:N.247, A:R.361, A:T.381
PEG.24: 4 residues within 4Å:- Chain A: W.16, M.20, C.21, A.112
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:C.21, A:C.21
PEG.38: 10 residues within 4Å:- Chain A: L.244, S.245, W.246
- Chain B: L.244, S.245, W.246, Q.249, S.273, Q.275
- Ligands: EDO.16
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:W.246, A:Q.249, B:W.246, B:Q.249, B:S.273, B:S.273
- Water bridges: A:N.247
PEG.39: 7 residues within 4Å:- Chain A: G.240, N.241, F.242
- Chain B: W.246, N.247, N.377
- Ligands: EDO.16
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:N.247, B:N.377, A:G.240
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Artola, M. et al., Alpha-d-Gal-cyclophellitol cyclosulfamidate is a Michaelis complex analog that stabilizes therapeutic lysosomal alpha-galactosidase A in Fabry disease. Chem Sci (2019)
- Release Date
- 2019-10-09
- Peptides
- Alpha-galactosidase A: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x ACT: ACETATE ION(Non-functional Binders)
- 11 x SO4: SULFATE ION(Non-functional Binders)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x YTW: (3~{a}~{R},4~{S},5~{S},6~{S},7~{R},7~{a}~{S})-7-(hydroxymethyl)-2,2-bis(oxidanylidene)-3~{a},4,5,6,7,7~{a}-hexahydro-3~{H}-benzo[d][1,2,3]oxathiazole-4,5,6-triol(Non-covalent)
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Artola, M. et al., Alpha-d-Gal-cyclophellitol cyclosulfamidate is a Michaelis complex analog that stabilizes therapeutic lysosomal alpha-galactosidase A in Fabry disease. Chem Sci (2019)
- Release Date
- 2019-10-09
- Peptides
- Alpha-galactosidase A: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B